Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 8/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.42 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11344391 | 0.86 | ACHE (0.41) | ACHEEPHX1BCHECHRNB2CHRNB4 | |
| SCHEMBL10512790 | 0.83 | EPHX1 (0.68) | ACHEEPHX1 | |
| SCHEMBL29277008 | 0.82 | ACHE (0.36) | ACHEEPHX1MEN1KMT2AALDH1A1 | |
| SCHEMBL10438939 | 0.82 | ACHE (0.36) | ACHEEPHX1MEN1KMT2AALDH1A1 | |
| SCHEMBL766364 | 0.82 | ACHE (0.36) | ACHEEPHX1MEN1KMT2AALDH1A1 | |
| SCHEMBL10885575 | 0.81 | ACHE (0.43) | ACHEEPHX1BCHECHRNB2CHRNB4 | |
| SCHEMBL22289460 | 0.80 | ACHE (0.53) | ACHEEPHX1BCHE | |
| SCHEMBL766292 | 0.79 | PAOX (0.44) | ACHEEPHX1MEN1KMT2A | |
| SCHEMBL12363095 | 0.77 | HSD17B10 (0.42) | ACHEEPHX1BCHECHRNB2CHRNB4 | |
| SCHEMBL27927783 | 0.77 | MMP1 (0.39) | ACHEEPHX1BCHECHRNB2CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10428012-B2 | Method of preparation of 4-isopropylamino-1-butanol | SEASONS BIOTECHNOLOGY CO., LTD. (CN) | 2019-10-01 | — | — | US | disclosed |
| US-20190084921-A1 | METHOD OF PREPARATION OF 4-ISOPROPYLAMINO-1-BUTANOL | SEASONS BIOTECHNOLOGY TAIZHOU CO LTD (CN) | 2019-03-21 | — | — | US | disclosed |
| US-10144701-B2 | Method for preparing 4-isopropylamino-1-butanol | Seasons Biotechnology (Taizhou) Co., Ltd. (CN) | 2018-12-04 | — | — | US | disclosed |
| US-20180029973-A1 | METHOD FOR PREPARING 4-ISOPROPYLAMINO-1-BUTANOL | Seasons Biotechnology (Taizhou) Co., Ltd. (CN) | 2018-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190084921-A1 | METHOD OF PREPARATION OF 4-ISOPROPYLAMINO-1-BUTANOL | ADH1A, ADH1C, ADH5 | ACHE 2239/4885EPHX1 2582/4885BCHE 816/4885 |
| US-10428012-B2 | Method of preparation of 4-isopropylamino-1-butanol | ADH1A, ADH1C, ADH5 | ACHE 2239/4885EPHX1 2582/4885BCHE 816/4885 |
| US-20180029973-A1 | METHOD FOR PREPARING 4-ISOPROPYLAMINO-1-BUTANOL | ADH1A, ADH1C, ADH5 | ACHE 2519/4885EPHX1 1933/4885BCHE 976/4885 |
| US-10144701-B2 | Method for preparing 4-isopropylamino-1-butanol | ADH1A, ADH1C, ADH5 | ACHE 2519/4885EPHX1 1933/4885BCHE 976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.